Brian O Mahony/ X
Jul 19, 2026, 07:47
Brian O. Mahony: Conclusions on Use of Low Dose Emicizumab by Patil ISTH 2026
Brian O Mahony, CEO of Irish Haemophilia Society, shared a post on X:
“Conclusions on use of low dose Emicizumab by Patil ISTH2026
Half dose seems as effective as full dose in study of 773 PWH ( inhibitor or non inhibitor) between 3 doses -full,half or quarter. Important data for resource constrained countries.”
Stay updated with Hemostasis Today.
-
Oct 18, 2026, 15:21Eleonora Gambineri: First Results of the IEI-Haem Consortium at ESID 2026
-
Oct 18, 2026, 15:17Alexey Kulikov: Could Platelets Reveal Frailty Before Physical Signs Appear?
-
Oct 18, 2026, 15:06Elisa Rossi: Advancing HHT Research at the 16th International Conference
-
Oct 18, 2026, 14:58Aishwarya Dash: Simplifying Bone Marrow Mesenchymal Stromal Cell Isolation
-
Oct 18, 2026, 14:54Caitlin Raymond: Could the Apheresis Circuit Itself Modulate Immunity?
-
Oct 18, 2026, 13:0810 Posts Not to Miss This Week
-
Oct 18, 2026, 12:58Pierpaolo Di Micco: DOACs vs Vitamin K Antagonists in Long-Term Anticoagulation
-
Oct 18, 2026, 12:51Arianne Missimer: Understanding Ferritin Levels Beyond the Normal Range
-
Oct 18, 2026, 12:37Roberto C. Iglesias: Colon Cancer Prevention Beyond Supplements and Vitamins